Magna Mining targets mid-2028 Levack mine restart after PEA shows after-tax NPV(7%) of C$ 227 million
Bitget2026/10/08 10:45Magna Mining released a NI 43-101 PEA for restarting the fully permitted Levack underground mine in Ontario. Study outlines 7.3 years of commercial production from mid-2028, averaging 36.8 million lb payable CuEq annually at AISC US$ 3.71/lb. Base-case economics show after-tax NPV(7%) C$ 227 million, after-tax IRR 92.4%, payback 0.6 years. Initial capital estimated at C$ 70.1 million, offset by C$ 55.9 million pre-commercial cash flow, net initial funding C$ 8.6 million. Board authorized a production restart plan, with underground development and surface construction expected to ramp up in coming months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Magna Mining Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080645PRIMZONEFULLFEED9841908) on October 08, 2026, and is solely responsible for the information contained therein.
- Magna Mining released a NI 43-101 PEA for restarting the fully permitted Levack underground mine in Ontario.
- Study outlines 7.3 years of commercial production from mid-2028, averaging 36.8 million lb payable CuEq annually at AISC US$ 3.71/lb.
- Base-case economics show after-tax NPV(7%) C$ 227 million, after-tax IRR 92.4%, payback 0.6 years.
- Initial capital estimated at C$ 70.1 million, offset by C$ 55.9 million pre-commercial cash flow, net initial funding C$ 8.6 million.
- Board authorized a production restart plan, with underground development and surface construction expected to ramp up in coming months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
